![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Novacyt S.a. | LSE:NCYT | London | Ordinary Share | FR0010397232 | EUR1/15TH (CDI) |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 47.00 | 46.10 | 48.00 | - | 2,010 | 08:56:15 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
In Vitro,in Vivo Diagnostics | 11.58M | -28.29M | - | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
25/2/2020 11:50 | IRAN DEPUTY HEALTH MINISTER TESTS POSITIVE FOR CORONAVIRUS - ILNAFollow the story live: bit.ly/rbgsgnup | tidy 2 | |
25/2/2020 11:42 | +11.7% in Paris. | ![]() fuji99 | |
25/2/2020 11:37 | Lots of news about tenerife | ![]() bob1995 | |
25/2/2020 11:37 | the way biotechs work is you buy into before results, by that time the share price is sky high, look at this stock, no financial statements to look over, earnings per share. but this moderna is a bigger cap stock which the americans will buy into and institutes, the number of traders /investors in the us outnumber the uk easily. and this drug will sell for thousands of dollars per patient imo. and as it is larger cap stock it will allow millions of dollars in trades and that means institutes with billions to place into potential stocks. kerching!!!!!!!!!!!! | ![]() datait2 | |
25/2/2020 11:31 | Trails not happening until end of April!! | nicktrade81 | |
25/2/2020 11:31 | https://www.laopinio | ![]() tez123 | |
25/2/2020 11:30 | may shove money into MODERNA INC (MRNA) at 2.30pm in us stocks, hope you all have a w-bBEN form to buy US stocks, i do. can you imagine the share price once its cure gets shipped, !!! | ![]() datait2 | |
25/2/2020 11:29 | can't give drugs/cure to those that are negative. People need to be tested for treatment and isolation. | nicktrade81 | |
25/2/2020 11:28 | Drugmaker Moderna Inc. has shipped the first batch of its rapidly developed coronavirus vaccine | ![]() datait2 | |
25/2/2020 11:28 | Looking like a good day, every buy pushing up sp | ![]() milliecusto | |
25/2/2020 11:25 | Forum NOVACYT 1.7700 EUR +11.32% | ![]() geoff0458 | |
25/2/2020 11:25 | Forum NOVACYT 1.7700 EUR +11.32% | ![]() geoff0458 | |
25/2/2020 11:25 | it is cures they need dope. | ![]() datait2 | |
25/2/2020 11:24 | That will go the same way as the cruise. Nearly all will be positive. | tidy 2 | |
25/2/2020 11:24 | The cause includes testing you dope. | tidy 2 | |
25/2/2020 11:23 | 1 billion dollars it seems into drugs and cures, not tests unfortunately and now we hear the usa has its own test company to rival ncyt. which stock is nearest a cure, then own that one i say. | ![]() datait2 | |
25/2/2020 11:23 | The Spanish hotel will be in the media non stop now.. | still waiting | |
25/2/2020 11:22 | 675m dollars being ploughed the cause guys. hTTps://www.who.int/ | tidy 2 | |
25/2/2020 11:20 | Coronavirus warning: Travellers from lockdown zones in Italy must self-isolate | ![]() rosco230667 | |
25/2/2020 11:18 | This is my own opinion: The situation this week is similar to that when people panicked and sold at 60p then see the share price recover to go up sharply later. Now, we are almost there to get some positive news probably this week and any impatient will be in the same situation if he/she sells. So those who don't want to be left left out of the game are either buying or topping up. Those who sell will find themselves hitting their heads against the wall in a similar way as those who panicked and sold at 60p. | ![]() fuji99 | |
25/2/2020 11:14 | should easily hit 220 Euros today | ![]() inv | |
25/2/2020 11:13 | I have a funny feeling this may top the 220 today just on speculation:)) | ![]() g2theary | |
25/2/2020 11:09 | buys flying in. | still waiting |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions